Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Association of HLA-DRB1*0901 with microscopic polyangiitis

Journal of Rheumatology

Volumn 30, Issue 7, 2003, Pages 1534-1540

  Tsuchiya, Naoyuki ^a,b   Kobayashi, Shigeto ^c   Kawasaki, Aya ^a   Kyogoku, Chieko ^a   Arimura, Yoshihiro ^c   Yoshida, Masaharu ^c   Tokunaga, Katsushi ^a   Hashimoto, Hiroshi ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NONE

Author keywords

Antineutrophil cytoplasmic antibody; HLA; Microscopic polyangiitis genetics; Susceptibility

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIB; FC RECEPTOR IIIA; FC RECEPTOR IIIB; HLA DR ANTIGEN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROMOTER REGION; RACE; VASCULITIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; PEROXIDASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VASCULITIS;

EID: 0037829127     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-23.
2. Csernok E, Trabandt A, Gross WL. Immunogenetic aspects of ANCA-associated vasculitides. Editorial overview. Exp Clin Immunogenet 1997;14:177-82.
3. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
4. Esnault VL, Audrain MA, Sesboue R. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis. Exp Clin Immunogenet 1997;14:206-13.
5. Spencer SJ, Burns A, Gaskin G, Pusey CD, Rees AJ. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992;41:1059-63.
6. Gencik M, Borgmann S, Zahn R, et al. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1999;117:412-7.
7. Papiha SS, Murty GE, Ad'Hia A, Mains BT, Venning M. Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis 1992;51:246-8.
8. Hagen EC, Stegeman CA, D'Amaro J, et al. Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis. Kidney Int 1995;48:801-5.
9. Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyama Y. The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis in a Japanese population. Rhinology 1996;34:163-5.
10. Cotch MF, Fauci AS, Hoffman GS. HLA typing in patients with Wegener granulomatosis [letter]. Ann Intern Med 1995; 122:635.
11. Fujii A, Tomizawa K, Arimura Y, et al. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol 2000;53:242-52.
12. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
13. Huang D, Giscombe R, Zhou Y, Lefvert AK. Polymorphisms in CTLA-4 but not tumor necrosis factor-a or interleukin 1b genes are associated with Wegener's granulomatosis. J Rheumatol 2000;27:397-401.
14. Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999;53:527-33.
15. Tsuchiya N, Komata T, Matsushita M, Ohashi J, Tokunaga K. New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus. Genes Immun 2000;1:501-3.
16. Barton A, John S, Ollier WE, Silman A, Worthington J. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 2001;44:61-5.
17. Douni E, Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin a, or the p55TNF-R. J Exp Med 1998;188:1343-52.
18. Dijstelbloem HM, van de Winkel JG, Kallenberg CG. Inflammation in autoimmunity: receptors for JG revisited. Trends Immunol 2001;22:510-6.
19. Salmon JE, Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001;44:739-50.
20. Kyogoku C, Dijstelbloem HM, Tsuchiya N, et al. Association of Fcg receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to the genetic susceptibility to SLE. Arthritis Rheum 2002;46:1242-54.
21. Tse WY, Abadeh S, Jefferis R, Savage COS, Adu D. Neutrophil FcgRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol 2000;119:574-7.
22. Dijstelbloem HM, Scheepers RH, Oost WW, et al. Fcg receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum 1999;42:1823-7.
23. Zhou Y, Huang D, Hoffman GS. Genetic polymorphisms in TNF, IL-1, IL-6 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in Wegener's granulomatosis (WG) [abstract]. Arthritis Rheum 2001;44 Suppl:S344.
24. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
25. Hattori M, Kurayama H, Koitanashi Y. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 2001;12:1493-500.
26. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-53.
27. Shibue T, Tsuchiya N, Komata T, et al. Tumor necrosis factor a 5′-flanking region, tumor necrosis factor receptor II, and HLA-DRB 1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000;43:753-7.
28. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNF a promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun 2000;1:351-7.
29. Tokunaga K, Imanishi T, Takahashi K, Juji T. On the origin and dispersal of East Asian populations as viewed from HLA haplotypes. In: Akazawa T, Szathmary EJ, editors. Prehistoric Mongoloid dispersals. Oxford: Oxford University Press; 1996:187-97.
30. Kawai S, Maekawajiri S, Tokunaga K, et al. Routine low and high resolution typing of the HLA-DRB gene using the PCR-MPH (microtitre plate hybridization) method. Eur J Immunogenet 1996;23:471-86.
31. Tsuchiya N, Kawasaki A, Tsao BP, Komata T, Grossman JM, Tokunaga K. Analysis of the association of HLA-DRB 1, TNFa promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001; 2:317-22.
32. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998;51:605-12.
33. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991. Volume 1. Oxford: Oxford University Press; 1992:1065-220.
34. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 2001;60:170-2.
35. Matsuki K, Juji T, Tokunaga K, et al. HLA antigens in Japanese patients with myasthenia gravis. J Clin Invest 1990;86:392-9.
36. Kawabata Y, Ikegami H, Kawaguchi Y, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002;51:545-51.
37. Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T. The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Scand J Rheumatol 1998;27:381-2.
38. Hashimoto H, Yamanaka K, Tokano Y, et al. HLA-DRB1 alleles and b2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:423-7.
39. Matsushita M, Tsuchiya N, Nakayama T, et al. Allele typing of human TNFA 5′-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese. Tissue Antigens 1999;54:478-84.
40. Criswell LA, Peden EA, Lum RF, et al. Association of FcgR2A & 3A genotypes with SLE: Analysis of 605 SLE families [abstract] Arthritis Rheum 2001;44 Suppl:S393.